Report cover image

Monoclonal Antibody Therapeutics Market

Published Jul 30, 2025
Length 335 Pages
SKU # CMI20302812

Description

The immune system is made up of a complex team of players that detect and destroy disease-causing agents, such as bacteria and viruses. Similarly, this system may eliminate damaged cells, such as cancer cells. One way the immune system finds and destroys invaders is with antibodies. Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAbs) to bind monospecifically to certain cells or proteins. The objective is that this treatment will stimulate the patient's immune system to attack those cells. Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. Also, there was a boost in the development of monoclonal antibody therapeutics for the treatment of COVID-19 in the year 2020

Market Dynamics

Increasing adoption of growth strategies, such as authorization by key regulatory authorities in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in February 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a new monoclonal antibody, bebtelovimab manufactured by Lilly, a pharmaceutical company for the treatment of COVID-19 that retains activity against the omicron variant.

Key features of the study
  • This report provides in-depth analysis of the global monoclonal antibody therapeutics market, and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global monoclonal antibody therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study are Pfizer Inc., Novartis AG, Bayer AG, Sanofi, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Merck KGaA, GSK plc., AbbVie Inc., Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., AstraZeneca, AbCellera Biologics Inc., Molecular Depot LLC, DAIICHI SANKYO COMPANY, LIMITED., Abbott, Biogen, Thermo Fisher Scientific, Inc., Cell Signaling Technology, Inc, Intas Pharmaceuticals Ltd., Avantor Inc., UCB S.A., Merus N.V., GENEXTGENOMICS.COM, Biogenuix.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global monoclonal antibody therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monoclonal antibody therapeutics market.
Market Segmentation
  • Global Monoclonal Antibody Therapeutics Market, By Source
  • Human
  • Chimeric
  • Murine
  • Humanized
  • Global Monoclonal Antibody Therapeutics Market, By Application
  • Cancer
  • Autoimmune Disease
  • Hematological Disease
  • Infectious Disease
  • Others
  • Global Monoclonal Antibody Therapeutics Market, By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Global Monoclonal Antibody Therapeutics Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Sanofi
  • Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
  • Merck KGaA
  • GSK plc
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Regeneron Pharmaceuticals Inc.
  • AstraZeneca
  • AbCellera Biologics Inc.
  • Molecular Depot LLC
  • DAIICHI SANKYO COMPANY LIMITED
  • Abbott
  • Biogen
  • Thermo Fisher Scientific, Inc.
  • Cell Signaling Technology, Inc.
  • Intas Pharmaceuticals Ltd.
  • Avantor Inc.
  • UCB S.A.
  • Merus N.V.
  • GENEXTGENOMICS.COM
  • Biogenuix

Table of Contents

335 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Source
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Highlights
Product Launch
Technological Advancements
PEST Analysis
Regulatory Scenario
Mergers and Acquisitions
4. Global Monoclonal Antibody Therapeutics Market, By Source, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Human
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Chimeric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Murine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Humanized
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
5. Global Monoclonal Antibody Therapeutics Market, By Application, 2020 – 2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Autoimmune Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Hematological Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Infectious Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
6. Global Monoclonal Antibody Therapeutics Market, By Distribution Channel, 2020 – 2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segments Trends
Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
7. Global Monoclonal Antibody Therapeutics Market, By Region, 2020 – 2032, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2032
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (USD Bn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
F. Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Merck KGaA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
GSK plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
AbbVie Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Regeneron Pharmaceuticals Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
AbCellera Biologics Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Molecular Depot LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
DAIICHI SANKYO COMPANY, LIMITED
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Abbott
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Biogen
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Thermo Fisher Scientific, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Cell Signaling Technology, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Intas Pharmaceuticals Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Avantor, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
UCB S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Merus N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
GENEXTGENOMICS.COM
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Biogenuix
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
9. Section
Research Methodology
About Us
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.